Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Eloxx Pharmaceuticals Hires New CEO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Eloxx Pharmaceuticals Hires New CEO

Robert Ward was also appointed chairman of the board of directors

By: Betsy Louda

, Contract Pharma

Eloxx Pharmaceuticals announced that Robert (“Bob”) Ward has been appointed chairman of the board of directors of Eloxx, and chief executive officer. Bob joins at a critical inflection point for Eloxx as the company advances its lead candidate ELX-02, a novel translational read-through inducing drug (TRID), through the completion of Phase 1 clinical trials and navigates its transition from a private to a public company.

 

Mr. Ward comes with more than 30 years of experience as a global biopharmaceutical industry leader with experience across the full spectrum of drug development, commercialization, and strategic business development transactions. He most recently was the president and chief executive officer of Radius Health, Inc.

 

“We are pleased to have attracted an experienced leader with Bob’s proven track record of success to Eloxx,” said Dr. Robert Heft.  “Having previously lead a fully integrated commercial biopharmaceutical company to achieve its first drug approval and product launch, we are confident that Bob is the right leader to advance Eloxx as we seek to develop and commercialize our novel small molecule medicines to treat rare and ultra-rare genetic diseases.”

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters